EligibleTrials

Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain

Recruiting · NCT06793982 · Interventional (participants receive a specific treatment) · Lead sponsor: LifeBridge Health

View the official record on ClinicalTrials.gov →
Osteoarthritis

Interventions studied

Corticosteroid InjectionPlatelet Rich Plasma Joint Injection

What this trial is about

Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.

Who can take part

Age range
21 Years to 80 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)

Inclusion criteria

Exclusion criteria

Where it is running

1 location listed across 1 US state.

Read the full protocol, contacts and eligibility on ClinicalTrials.gov →

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.